Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2007
12/12/2007EP1864979A1 Imidazole-derivatives as TAFAIa-inhibitors
12/12/2007EP1864977A1 Novel cyclic compound having pyrimidinylalkylthio group
12/12/2007EP1864975A2 Novel compounds
12/12/2007EP1863933A2 Dimeric and trimeric nucleic acid dyes, and associated systems and methods
12/12/2007EP1863833A2 Process for preparing macrocyclic compounds
12/12/2007EP1863812A1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
12/12/2007EP1863805A1 Pyrimidine compounds having tie2 (tek) inhibitory activity
12/12/2007EP1863798A1 Indole derivatives
12/12/2007EP1863795A1 Substituted triazole derivatives as oxytocin antagonists
12/12/2007EP1863794A2 Pyrimidine compounds and methods of use
12/12/2007EP1863793A2 Hepatitis c virus inhibitors
12/12/2007EP1863792A1 Atp competitive kinase inhibitors
12/12/2007EP1863791A1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists
12/12/2007EP1863790A1 Amide-substituted 8-n-benzimidazoles, method for the production thereof, and use of the same as medicaments
12/12/2007EP1863789A1 Aminocarbonyl-substituted 8-n-benzimidazoles, method for their production and their use as medicaments
12/12/2007EP1863788A1 A novel crystalline form of rupatadine free base
12/12/2007EP1863771A2 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors
12/12/2007EP1863764A1 Process for the preparation of opioid modulators
12/12/2007EP1863490A2 Muscarinic modulators
12/12/2007EP1863488A2 Use of amino-substituted 8-n-benzimidazoles
12/12/2007EP1863484A1 Substituted triazole derivatives as oxytocin antagonists
12/12/2007EP1863483A1 Bicyclic pyrazole compounds as antibacterial agents
12/12/2007EP1863477A1 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
12/12/2007EP1752452A9 Propane-1,3-dione derivative or its salt
12/12/2007EP1644357B1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
12/12/2007EP1564212B1 Process and intermediates for obtaining 1-(1h-benzimidazol-2-yl)-4-(pyrimidin-2-ylamino)piperidine derivatives
12/12/2007EP1551824B1 Protein tyrosine kinase inhibitors
12/12/2007EP1492794B1 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
12/12/2007EP1470120B1 N-oxyde of n-phenyl-2-pyrimidine-amine derivatives
12/12/2007EP1406623B1 Substituted 1-phenethylpiperidine compounds used as inter alia analgesics
12/12/2007EP1399443B1 Nitrogen-containing bicyclic heterocycles for use as antibacterials
12/12/2007EP1327630B1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
12/12/2007EP1276738B1 2-amino-3-(alkyl)-pyrimidone derivatives as gsk3.beta. inhibitors
12/12/2007EP0927174B1 New amino alcohol derivatives, process for the production thereof and medicaments and reagents containing these compounds
12/12/2007CN101087792A Synthetic process for preparing dual loop compound
12/12/2007CN101087778A Pyrrolidyl derivatives of heteroaromatic compounds as phosphodiesterase inhibitors
12/12/2007CN101087776A Organic compound, charge-transporting material, and organic electroluminescent element
12/12/2007CN101087775A Azole derivatives with antimuscarinic activity
12/12/2007CN101087764A Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents
12/12/2007CN101087755A Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
12/12/2007CN101085759A Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/12/2007CN101085758A 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivative, preparation method and application thereof
12/12/2007CN100354285C Neutral metallic dendrimer complexes
12/12/2007CN100354273C Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/12/2007CN100354271C Piperazine derivatives and process for the preparation thereof
12/12/2007CN100354263C Process for the preparation of 7-substituted-3-quinoline and 3-quinol-4-one carbonitriles
12/12/2007CN100354262C Sterically hindered amine compound
12/11/2007US7307095 Osteoporosis; antiarthritic agents; antidiabetic agents; antiinflammatory agents; Alzheimer's disease; shock; central nervous stsrem disorders; anticancer agents; multiple sclerosis, (S)-2-(Benzooxazol-2-ylamino)-3-cyclohexyl-N-[2-(5-fluoro-2,3-dihydro-indol-1-yl)-ethyl]-propionamide
12/11/2007US7307090 Piperidine derivatives useful as modulators of chemokine receptor activity
12/11/2007US7307088 Substituted anthranilic amide derivatives and methods of use
12/11/2007US7307087 Antidepressants; analgesics; antiinflammatory agents; side effect reduction
12/11/2007US7307086 3-(4-heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors
12/11/2007US7307081 Treatment of Human Immunodeficiency Virus, organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
12/11/2007US7307079 Treating acute and chronic pain and inflammatory, gastrointestinal, allergic, cardiovascular, skin, opthalmological, respiratory, nervous system, cognition and memory disorders, etc.
12/11/2007US7307075 Tetrahydroquinoline analogues as muscarinic agonists
12/11/2007US7307074 Diazepan derivatives or salts thereof
12/11/2007CA2393271C Retroviral protease inhibiting compounds
12/06/2007WO2007140183A1 Fxr agonists
12/06/2007WO2007140174A2 Compounds and methods for modulating fxr
12/06/2007WO2007139968A2 Triazole compounds that modulate hsp90 activity
12/06/2007WO2007139955A2 Triazole compounds that modulate hsp90 activity
12/06/2007WO2007139797A2 Method of preparing 4-halogenated quinoline intermediates
12/06/2007WO2007139496A1 Quinoline derivatives acting as tyrosine kinase inhibitors
12/06/2007WO2007139464A1 Isoindole derivatives useful for treating pain, gastrointestinal diseases and cancer
12/06/2007WO2007139230A1 Seven-membered ring compound, production method thereof and pharmaceutical use thereof
12/06/2007WO2007139211A1 Process for production of optically active piperidine compound
12/06/2007WO2007139149A1 Compound for biological reagent
12/06/2007WO2007138994A1 Hsp90 inhibitor
12/06/2007WO2007138343A1 N-phenylamidines as 5-ht2a receptor antagonists
12/06/2007WO2007138051A1 Dibenzorylenetetracarboximides as infrared absorbers
12/06/2007WO2007137980A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007WO2007137955A1 Piperidinyl pyrimidine derivatives
12/06/2007WO2007137791A1 Aryl-substituted heterocycles, and use thereof
12/06/2007WO2007118185A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
12/06/2007WO2007110834A3 Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
12/06/2007WO2007105053A3 Tetralines antagonists of the h-3 receptor
12/06/2007WO2006110763A9 Pyrimidine derivatives and their use for the treatment of cancer
12/06/2007US20070282112 5-(oximinoalkyl- and hydrazonalkyl-amino)pyrazoles; controlling arthropods and helminths
12/06/2007US20070282100 Boronic ester and acid compounds, synthesis and uses
12/06/2007US20070281971 Novel Compound
12/06/2007US20070281953 Substituted Dihydroquinazolines II
12/06/2007US20070281952 Arylsulfonylnaphthalene Derivatives As 5Ht2a Antagonists
12/06/2007US20070281950 1-((6-chloropyridin-3-yl)methyl)-8-nitro-1,2,3,5,6,7-hexahydro imidazo[1,2-a]pyridin-5-ol; 1-((6-chloropyridin-3-yl)methyl)-5-methoxy-8-nitro-1,2,3,5,6,7-hexahydroimidazo[1,2-a]pyridine; increased photostability and liposolubility
12/06/2007US20070281939 5-(3,5-Dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(1-hydroxy-cycloheptylmethyl)benzamide derivatives in which the triazine ring has various 4-substituents, e.g., carbamoylmethyl-, dimethylaminoethyl-, acetylaminoethyl-, and pyridinylmethyl-; treating rheumatoid arthritis
12/06/2007US20070281938 Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
12/06/2007US20070281936 To reducte the purinergic neurotransmission; Parkinson's disease; dyskinesias; Movement disorders; Adenosine receptors antagonists; 2-Methylamino-6-(5-methyl-2-furyl)-N-(2-pyridylmethyl)pyrimidine-4-carboxamide
12/06/2007US20070281934 Indole derivatives as inhibitors of histone deacetylase
12/06/2007US20070281930 bicyclic bisamides for controlling acarina
12/06/2007US20070281928 Fused Ring Azadecalin Glucocorticoid Receptor Modulators
12/06/2007US20070281363 Luminescent compounds
12/06/2007CA2653667A1 7-membered ring compound and method of production and pharmaceutical application thereof
12/06/2007CA2653529A1 Pyridinone and pyridazinone derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/06/2007CA2653332A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653329A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2653319A1 Hsp90 inhibitor
12/06/2007CA2653222A1 Triazole compounds that modulate hsp90 activity
12/06/2007CA2652636A1 Nitrated heterocyclic compounds as endothelin receptor antagonist
12/06/2007CA2652158A1 Piperidinyl pyrimidine derivatives
12/06/2007CA2651448A1 Method of preparing 4-halogenated quinoline intermediates
12/06/2007CA2651373A1 Compounds and methods for modulating fxr
1 ... 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 ... 1080